A randomised controlled trial of biopsy forceps and cannula aspiration for transcervical chorionic villus sampling

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 5, 2005, Pages 559-566

  Von Dadelszen, Peter ^a,c   Sermer, Mathew ^a   Hillier, Joan ^a   Allen, Lynn C ^a   Fernandes, Bernie J J ^b   Johnson, Jo Ann M ^a   Shime, Jerry ^a   Winsor, Elizabeth J T ^b   Ryan, Greg ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; ASPIRATION BIOPSY; CANNULA; CHORION VILLUS SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; CYTOGENETICS; ECONOMIC ASPECT; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OPERATOR; PATIENT SATISFACTION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX BIOPSY;

ALPHA-FETOPROTEINS; BIOPSY, NEEDLE; CATHETERIZATION; CHORIONIC VILLI SAMPLING; CYTOGENETIC ANALYSIS; EQUIPMENT DESIGN; FEMALE; FETOMATERNAL TRANSFUSION; HUMANS; OBSTETRICAL FORCEPS; PATIENT SATISFACTION; PREGNANCY; PREGNANCY OUTCOME; SURGICAL INSTRUMENTS;

EID: 18744362444     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00483.x     Document Type: Article

References (27)

1. Rodeck CH, Morsman JM, Nicolaides KH, et al. A single operator technique for first trimester chorion biopsy. Lancet 1983; ii:1340.
2. Ward RHT, Modell B, Petrou M, et al. Method of sampling chorionic villi in first trimester of pregnancy under guidance of real-time ultrasound. BMJ 1983;286:1542-1554.
3. ACOG Committee on Genetics. Chorionic villus sampling. Committee Opinion 1995:160.
4. Jackson LG, Wapner RJ. Risks of chorion villus sampling. Ballière's Clin Obstet Gynecol 1987;1:513-531.
5. Pons JC, Fernandez H, Eydoux P, et al. Chorionic villus sampling (CVS). Randomized study of efficacy of two transcervical biopsy methods: aspiration cannulas and small forceps. Eur J Obstet Gynecol Reprod Biol 1989;32:187-194.
6. Holmes LB. Report of National Institute of Child Health and Human Development Workshop on chorionic villus sampling and limb and other defects October 20, 1992. Teratology 1993;48:7-13.
7. Firth HV, Boyd PA, Chamberlain P, et al. Severe limb abnormalities after chorionic villus sampling at 56-66 days' gestation. Lancet 1991; 337:762-763.
8. Rodeck CH. Commentary: prenatal diagnosis; fetal development after chorionic villus sampling. Lancet 1993;341:468-469.
9. Tabor A, Bang J, Nørgaard-Pedersen B. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987;94:528-534.
10. Nicolaides KH, Brizot ML, Patel F, Snjders R. Comparison of chorion villus sampling and early amniocentesis for karyotyping in 1,492 singleton pregnancies. Fetal Diagn Ther 1996;11:9-15.
11. Jackson L. Transcervical and transabdominal chorionic villus sampling are comparably safe procedures for first trimester prenatal diagnosis: preliminary analysis. USHICHD Collaborative CVS study group. Am J Hum Genet 1990;47(Suppl 3):A278.
12. Fortuny A, Casals E, Soler A, et al. Changes in maternal serum AFP after transcervical CVS by two methods. Proceedings of the Symposium of the European Society of Human Genetics: Genetics in the 21st Century. Corfu, Greece, 1990. Abstract 162.
13. Fortuny A, Borrell A, Soler A, et al. Chorionic villus sampling by biopsy forceps. Results of 1580 procedures from a single centre. Prenat Diagn 1995;15:541-550.
14. Rodeck CH, Sheldrake S, Beattie B, et al. Maternal serum alphafeto-protein after placental damage in chorionic villus sampling [letter]. Lancet 1993;341:500.
15. Johnson JM. Chorionic villus sampling: introduction and techniques. In: Harman CR, editor. Invasive Fetal Testing and Treatment. Boston: Blackwell Scientific, 1995:21-46.
16. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-887.
17. Rosner B. Fundamentals of Biostastics, 3rd edition. Boston: PWS-Kent Publishing, 1990.
18. Kleihauer E, Braun H, Betke K. Klin Wschr 1957;35:637.
19. Gleicher N. Medical Therapy in Pregnancy, 2nd edition. Norwalk: Appleton and Lange, 1991.
20. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting randomised controlled trials: the CONSORT statement. JAMA 1996; 276:637-639.
21. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
22. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants bom between 25 and 44 weeks of gestation. J Pediatr 1969;74:901-910.
23. Smidt-Jensen S, Philip J, Zacharev JM, et al. Implications of maternal serum alpha-fetoprotein elevation caused by transabdominal and transcervical CVS. Prenat Diagn 1994;14:35-45.
24. Brambati B, Guercilena S, Bonacchi I, Oldrini A, Lanzani A, Piceni L. Feto-maternal transfusion after chorionic villus sampling. Hum Reprod 1986;1:37-40.
25. Gitlin D, Boesman M. Serum alpha-fetoprotein, albumin, and gamma G-globulin in the human conceptus. J Clin Invest 1966;45:1826-1838.
26. Nicolini U, Kochenour HK, Greco P, et al. Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ 1988;297:1379-1381.
27. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255-266.